TSS Celebrates WTISD 2024: Embracing Innovation, Digitalisation, and Sustainability

The assembly of a data logger, representing TSS's commitment to innovation and digitalisation for WTISD 2024.
World Telecommunication & Information Society Day (WTISD), celebrated annually on May 17th, highlights the pivotal role of digital technologies in fostering societal progress. This day serves as a reminder of the transformative power of innovation and digitalisation in building a sustainable future. At TSS, we are dedicated to leveraging advanced technologies to enhance the pharmaceutical supply chain while promoting sustainability.

Each year on May 17th, the global community celebrates World Telecommunication & Information Society Day (WTISD). This significant event, marking the founding of the International Telecommunication Union (ITU), underscores the transformative power of digital technologies in fostering societal progress and bridging the digital divide. As we reflect on WTISD 2024, TSS proudly supports the day’s mission by advancing innovation, digitalisation, and sustainability, particularly within the pharmaceutical supply chain.

WTISD’s roots date back to the signing of the first International Telegraph Convention in 1865 and the establishment of the ITU. The day serves as a platform to raise awareness about the potential of the Internet and information and communication technologies (ICTs) in shaping inclusive and sustainable societies. By promoting digital literacy and advocating for robust digital policies, WTISD aims to address the glaring digital gaps that hinder innovation in many regions across the globe.

Digital Innovation for a Sustainable Future

Building a sustainable future necessitates innovative thinking and decisive action, particularly in the digital realm. Digital technologies hold the potential to address some of the world's most pressing challenges, from climate change to global poverty. These technologies are pivotal in achieving 70% of the targets set under the United Nations Sustainable Development Goals (SDGs) by 2030. However, the lack of investment, policies, and digital skills in various parts of the world remains a significant barrier to realizing this potential.

TSS’s Role in Digital Innovation

At TSS, we are committed to contributing to digital innovation and sustainability, especially within the pharmaceutical industry. Temperature-sensitive pharmaceuticals, like vaccines and other biologics, are incredibly delicate. The European Pharmaceutical Review recently highlighted the complex logistics and supply chain challenges inherent in cell and gene therapy (CGT) development. CGT materials are highly sensitive to time and temperature fluctuations, necessitating strict control throughout the supply chain to ensure their viability.

Mitigating Drug Wastage through Temperature Management

One of the critical areas where we at TSS are making a substantial impact is in mitigating drug wastage caused by temperature excursions during transportation and storage. Drug wastage not only strains healthcare budgets but also limits the availability of essential doses to those in need. By implementing advanced temperature-monitoring technologies and stringent quality control measures, we can minimize wastage, thereby optimizing resource allocation and ensuring that important drugs reach their intended recipients in optimal condition.

Sustainability through E-Waste Management

In line with our commitment to sustainability, we implemented a robust e-waste management strategy to handle the hardware components used in temperature monitoring, such as plastic housings, microchips, batteries, and sensors. These components, if not properly managed, can negatively impact the environment. Our service model focuses on recycling and reusing these components, significantly reducing our environmental footprint. This initiative directly supports the UN Sustainable Development Goal 12, which advocates for responsible consumption and production.

A Circular Economy Approach

Under our circular economy approach, we offer our customers a lower price per logger with the assurance that all returned loggers will be recycled or properly disposed of. This model not only reduces waste but also lowers costs for our clients, aligning with both their sustainability goals and our corporate responsibility to minimize environmental impact.

As we celebrate WTISD 2024 at TSS, we reaffirm our dedication to leveraging digital innovation for a sustainable future. By addressing the unique challenges of the pharmaceutical supply chain and embracing sustainable practices, we are helping to build a world where digital technologies enhance health outcomes, promote sustainability, and drive inclusive growth. Our efforts are a testament to the power of innovation in overcoming barriers and achieving the UN Sustainable Development Goals.

Together, let us continue to harness the potential of digital technologies to create a more connected and sustainable world. Happy World Telecommunication & Information Society Day!

You may also be interested in

The TSS company logo, representing a change in the company's management.

Change in the Management of TSS

We are thrilled to announce a new chapter at TSS as we bid farewell to our esteemed CEO, Niclas Ohlsson.
Read moreDownload Whitepaper

Join us at Clinical Trial Supply Europe 2022

We are glad to announce that we’re exhibiting at the next Clinical Trial Supply Europe conference organized by Arena International.
Read moreDownload Whitepaper

On time and in full, when it matters most

When TSS received the request to support Sandoz, the Novartis generics and biosimilar division, from its client Novartis, a multinational pharmaceutical company based in Switzerland, citing their need for urgent support with surveillance of critical shipments related to a COVID-19, the obvious solution was TSS Real-Time Monitoring solution.
Read moreDownload Whitepaper

You may also be interested in

Can You Rely on the Results from Your Clinical Trials?

The success of a clinical trial depends on the reliability of its data. Many investigational drugs are sensitive to temperature, and any temperature deviation can affect their quality and, in the worst case, patient safety. Automated and integrated temperature monitoring solutions help secure data quality, support compliance, and speed up the delivery of new medicines to patients.
Read more

Extending TempMonitor BLE to Ultra-Low Temperatures

Introducing the new TSS Dry Ice Probes, enginereed for accurate and GxP-compliant temperature monitoring down to –90°C. Available in two lengths for flexible setup — built to safeguard product integrity in every environment.
Read more

Subscribe to our newsletter

Sign up for our newsletter to receive all the latest TSS news and insights in temperature management solutions.